142 related articles for article (PubMed ID: 9806656)
21. Uterine sarcoma: twenty-seven years of experience.
Livi L; Paiar F; Shah N; Blake P; Villanucci A; Amunni G; Barca R; Judson I; Lodge N; Meldolesi E; Simontacchi G; Piperno G; Galardi A; Scoccianti S; Biti GP; Harmer C
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1366-73. PubMed ID: 14630275
[TBL] [Abstract][Full Text] [Related]
22. Uterine sarcomas: a review of the Edinburgh experience from 1974 to 1992.
Tinkler SD; Cowie VJ
Br J Radiol; 1993 Nov; 66(791):998-1001. PubMed ID: 8281393
[TBL] [Abstract][Full Text] [Related]
23. Different types and different prognosis-study of 310 uterine sarcomas.
Nickie-Psikuta M; Gawrychowski K
Eur J Gynaecol Oncol; 1993; 14 Suppl():105-13. PubMed ID: 8200360
[TBL] [Abstract][Full Text] [Related]
24. Uterine sarcoma: analysis of prognostic variables in 71 cases.
Wheelock JB; Krebs HB; Schneider V; Goplerud DR
Am J Obstet Gynecol; 1985 Apr; 151(8):1016-22. PubMed ID: 2984936
[TBL] [Abstract][Full Text] [Related]
25. Results of postoperative radiotherapy in the treatment of 29 uterine sarcoma patients.
Etiz D; Garipağaoğlu M; Etiz EE; Köse FM; Kayikçioğlu F; Haberal A; Citak L; Cakmak A
Tumori; 2003; 89(2):183-8. PubMed ID: 12841668
[TBL] [Abstract][Full Text] [Related]
26. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
27. Treatment of uterine sarcoma at the University of Florence from 1980-2001.
Livi L; Paiar F; Meldolesi E; Simontacchi G; Amunni G; Barca R; Villanucci A; Scoccianti S; Piperno G; Biti G
Tumori; 2005; 91(2):139-43. PubMed ID: 15948541
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors and outcome in women with uterine sarcoma.
Denschlag D; Masoud I; Stanimir G; Gilbert L
Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
[TBL] [Abstract][Full Text] [Related]
29. [Postoperative radiotherapy of uterine sarcoma: a multicentric retrospective study].
Champetier C; Hannoun-Levi JM; Resbeut M; Azria D; Salem N; Tessier E; Ellis S; Cowen D;
Cancer Radiother; 2011 Apr; 15(2):89-96. PubMed ID: 20674447
[TBL] [Abstract][Full Text] [Related]
30. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
[TBL] [Abstract][Full Text] [Related]
31. Update on treatment of uterine sarcoma.
Nam JH; Park JY
Curr Opin Obstet Gynecol; 2010 Feb; 22(1):36-42. PubMed ID: 19923988
[TBL] [Abstract][Full Text] [Related]
32. Impact of adjuvant pelvic radiotherapy in stage I uterine sarcoma.
Magnuson WJ; Petereit DG; Anderson BM; Geye HM; Bradley KA
Anticancer Res; 2015 Jan; 35(1):365-70. PubMed ID: 25550573
[TBL] [Abstract][Full Text] [Related]
33. Postoperative vaginal cuff irradiation using high dose rate remote afterloading: a phase II clinical protocol.
Noyes WR; Bastin K; Edwards SA; Buchler DA; Stitt JA; Thomadsen BR; Fowler JF; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1439-43. PubMed ID: 7635785
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of treatment results and prognostic factors of uterine sarcoma: A single-center experience.
Momtahan M; Emami F; Sari Aslani F; Akbarzadeh-Jahromi M
J Chin Med Assoc; 2020 Jan; 83(1):84-88. PubMed ID: 31517774
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy in the treatment of uterine sarcomas. A retrospective analysis of 54 cases.
Hoffmann W; Schmandt S; Kortmann RD; Schiebe M; Dietl J; Bamberg M
Gynecol Obstet Invest; 1996; 42(1):49-57. PubMed ID: 8840179
[TBL] [Abstract][Full Text] [Related]
36. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
[TBL] [Abstract][Full Text] [Related]
37. Treatment of uterine sarcoma. A survey of 49 patients.
Soumarová R; Horová H; Seneklová Z; Ruzicková J; Horová I; Budíková M; Slampa P; Kalábová R
Arch Gynecol Obstet; 2002 Apr; 266(2):92-5. PubMed ID: 12049303
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL
Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
[TBL] [Abstract][Full Text] [Related]
39. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
40. Uterine sarcomas: a clinicopathologic study.
Chiara S; Foglia G; Odicino F; Graziani A; Conte PF; Ragni N; Fulcheri E; Pescetto G
Oncology; 1988; 45(6):428-33. PubMed ID: 3186152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
